The Pharmaceutical Innovation & Invention Index seeks to answer the provocative question, ‘If two pharma companies were given the same molecule in early phase, which of the two would be better in developing and launching it?”
The Innovation Index ranks companies utilizing a range of clinical, regulatory, and commercial metrics, ranging from the corporate level down to individual product decisions and outcomes.
This 13th annual Index provides a systematic and objective assessment of how well the top 30 companies perform in bringing new medicines to market and commercializing them successfully.
See the full results and download the report here
Subscribe to our newsletter for more insights.
Further reading
-
Industry
Despite / because of...
Despite the challenges, she succeeded in her career. Because of the challenges, she succeeded in her career.
-
Announcement
IDEA Pharma and Exploristics partnership
IDEA PHARMA AND EXPLORISTICS ANNOUNCE STRATEGIC PARTNERSHIP TO ENHANCE PATH-TO-MARKET STRATEGIES FOR BIOPHARMA BY IMPROVING CLINICAL PROBABILITY OF SUCCESS AND COMMERCIAL OUTCOMES
